Shares of Inovio Pharmaceuticals Inc. /zigman2/quotes/202993817/composite INO +0.23% shed 8.77% to $9.15 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.55% rising 0.78% to 14,020.33 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.80% rising 0.06% to 34,466.24. The stock's fall snapped a four-day winning streak. Inovio Pharmaceuticals Inc. closed $24.64 short of its 52-week high ($33.79), which the company reached on June 26th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.69% rose 1.96% to $116.24, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.79% rose 2.14% to $244.64, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.49% rose 2.15% to $58.84. Trading volume (7.6 M) remained 1.3 million below its 50-day average volume of 9.0 M.